Official data from INPI

122021001700

IndeferidaUtility ModelPCT · US2016014312

Talk to an expert

Application data

Number

122021001700

Type

Utility Model

Filing

01/21/2016

Publication

PCT

US2016014312

View on INPI

Progress at the INPI

Under appeal

Filing01/21/16
Publication
Examination
Refused08/08/23
Grant
In force

The application was refused by the INPI on 08/08/2023. The invention was never patented.

Talk to a specialist

Latest action published by the INPI: 08/08/2023. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

MITOCHON PHARMACEUTICALS, INC.

Inventors

No inventors listed.

Technical data

IPC Classification

No IPC classification.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Indeferimento

#9.2

08/08/2023

RPI 2744

Notificação de pedido dividido

#2.4

02/23/2021

RPI 2616

Requerimento de pedido de patente

#2.10

Número de Protocolo '870210009977' em 29/01/2021 11:26 (WB)

02/09/2021

RPI 2614

From the same holder

122021007069 COMPOSIÇÃO COMPREENDENDO PRÓ-FÁRMACO DE ISÔMERO DE DINITROFENOL (DNP) E USOS DA MESMA EXPRESSÃO INDUZIDA DE FATOR NEUROTRÓFICO DERIVADO DO CÉREBRO (BDNF) PARA O TRATAMENTO DE DOENÇAS NEUROMUSCULARES, NEURODEGENERATIVAS, AUTOIMUNES, DO DESENVOLVIMENTO E/OU METABÓLICAS.

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.